Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001431

Drug Information
Synonyms4-14-00-01172 (Beilstein Handbook Reference); Tetracainum; AC-3480; Pontocaine; Diaethylaminoaethanol ester der p-butylaminobenzoesaeure; 4-[Butylamino]benzoic acid-2-[dimethylamino]ethyl ester; NCGC00016049-02; NINDS_000607; tetracaine; 2-dimethylaminoethyl 4-(butylamino)benzoate; Uromucaesthin; 136-47-0 (mono-hydrochloride); CAS-136-47-0; 2-(Dimethylamino)ethyl 4-(butylamino)benzoate; Prestwick0_000571; Tetracaina; SPBio_002601; Dicaine; Prestwick1_000571; KBio2_001512; NCGC00162367-01; Spectrum_001032; BRD-K45071273-003-05-8; Dicain; Spectrum2_001328; T7383_SIAL; KBio3_001444; KBio2_006648; NCGC00016049-04; Prestwick3_000571; BSPBio_001944; Mucaesthin; Tetracaina [INN-Spanish]; Spectrum5_001072; Spectrum4_000351; Prestwick2_000571; Laudocaine; D00551; Medihaler-Tetracaine; Dikain; Lopac0_001211; I01-1872; BSPBio_000382; KBioSS_001512; CHEBI:9468; SPBio_001455; NCGC00016049-01; C15H24N2O2; C07526; Fissucain; SBB058194; T3812_SIAL; 4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester; BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE; Lopac-T-7508; InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H; EINECS 202-316-6; Amethocaine; AC1L1KAQ; Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester; Dimethylaminoethyl p-butyl-aminobenzoate; MolPort-001-783-476; 2-(Dimethylamino)ethyl p-(butylamino)benzoate; Contralgin; Tetrakain [Czech]; Tetrakain; LS-36312; DivK1c_000607; Meethobalm; Tetracaine (USP/INN); AB00053549; Anetain; Metraspray; Rexocaine; Medicaine; p-Butylaminobenzoyl-2-dimethylaminoethanol; UNII-0619F35CGV; Tetracainum [INN-Latin]; Tetracaine [USAN:INN]; CHEMBL698; T7383_SIGMA; BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER; KBioGR_000781; CID5411; Niphanoid; 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove; p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester; KBio2_004080; IDI1_000607; KBio1_000607; 2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]; BPBio1_000422; Spectrum3_000562; Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]; Amethocaine (TN); 94-24-6; Intercain; BRN 2216051
Trade NamePontocaine
IndicationSpinal anesthesia
[ICD9: 338   ICD10: R52]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnesthetics
CAS NumberCAS 94-24-6
PubChem Compound IDCID 5411.
PubChem Substance IDSID 9729.
SuperDrug ATC IDC05AD02; D04AB06; N01BA03; S01HA03
SuperDrug CAS ID000094246;
TargetVoltage-gated sodium channel subunit alpha Nav1.8Inhibitor[2]
Ref 1Evaluation of a novel topical anesthetic agent for cutaneous laser resurfacing: a randomized comparison study. Dermatol Surg. 2002 Nov;28(11):1004-6; discussion 1006. To Reference
Ref 2Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. Neuropharmacology. 2004 Mar;46(3):425-38. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543